Rx (Prescription Medicine)
USD $ 133.00
Mitotax 250mg 注射液是一种强效的化疗药物，用于治疗多种癌症。其活性成分帕克塞尔（Paclitaxel）属于紫杉醇类微管稳定剂。帕克塞尔通过促进微管的组装并防止其解聚，从而破坏细胞骨架的正常功能。这种破坏抑制细胞分裂，最终导致快速分裂的癌细胞凋亡（程序性细胞死亡）。
Mitotax 250mg 注射液适用于晚期卵巢癌、乳腺癌和非小细胞肺癌的治疗。它也可与其他化疗药物联合使用，用于治疗某些类型的卡波西肉瘤。Mitotax 250mg 注射液的剂量和给药方式应由合格的医疗专业人员根据患者的具体病情、对治疗的反应以及其他医学因素来确定。通常通过静脉给予。
常见不良反应可能包括骨髓抑制（导致血细胞计数下降）、周围神经病变（手脚麻木、刺痛或疼痛）、脱发、恶心、呕吐、腹泻以及过敏反应。患者应密切监测这些不良反应。Mitotax 250mg 注射液应储存在室温、避光的环境中，并置于儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Paclitaxel. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
